% | $
Quotes you view appear here for quick access.

TG Therapeutics, Inc. Message Board

  • slumdawg2011 slumdawg2011 Nov 1, 2013 2:34 PM Flag

    Roche anti-CD20 drug approved for CLL

    Breakthrough therapy, priority review. The trial showed that people who received Gazyva in combination with chlorambucil chemotherapy had significantly reduced risk of disease progression or death (HR=0.16; p

6.24-0.15(-2.35%)11:37 AMEDT